US Stock MarketDetailed Quotes

Caribou Biosciences (CRBU)

Watchlist
  • 1.650
  • -0.050-2.94%
Close Dec 29 15:59 ET
  • 1.660
  • +0.010+0.61%
Pre 05:22 ET
154.22MMarket Cap-0.97P/E (TTM)

Caribou Biosciences (CRBU) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.89%-25.19M
14.02%-28.26M
1.28%-36.73M
-48.14%-138.2M
-65.91%-35.47M
-13.45%-32.66M
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
Net income from continuing operations
20.57%-27.55M
-43.51%-54.1M
3.01%-39.99M
-46.08%-149.11M
-2.85%-35.49M
-246.77%-34.68M
-27.70%-37.7M
-47.03%-41.23M
-2.66%-102.07M
-27.85%-34.51M
Operating gains losses
--0
----
----
73.53%-9K
---13K
----
----
----
---34K
--0
Depreciation and amortization
-46.39%631K
36.33%1.17M
64.08%1.17M
11.40%3.93M
60.00%1.18M
-25.46%1.18M
38.74%856K
20.54%710K
117.32%3.53M
46.25%740K
Other non cash items
-43.30%457K
100.54%15K
-90.94%156K
-99.69%10K
-87.94%263K
21.02%806K
-1,744.97%-2.78M
561.92%1.72M
21,933.33%3.28M
415.48%2.18M
Change In working capital
50.11%-1.41M
-80.64%554K
-76.21%-1.5M
30.12%-5.11M
-185.63%-4.3M
87.20%-2.82M
-76.33%2.86M
64.06%-849K
-74.07%-7.32M
4,025.00%5.02M
-Change in receivables
-158.89%-149K
-105.74%-40K
108.16%510K
-24.47%608K
-145.93%-587K
118.15%253K
-36.64%697K
236.87%245K
-76.73%805K
284.94%1.28M
-Change in prepaid assets
273.31%461K
-42.95%340K
162.14%471K
-124.52%-433K
-100.55%-5K
82.31%-266K
9.36%596K
-141.86%-758K
281.13%1.77M
43.26%914K
-Change in payables and accrued expense
-149.95%-550K
-97.77%58K
-428.88%-1.7M
-76.46%1.78M
-167.20%-2.44M
-52.67%1.1M
-38.80%2.6M
119.58%516K
1,084.64%7.56M
306.85%3.63M
-Change in other current assets
95.01%-155K
791.19%1.42M
329.19%479K
-8,097.92%-3.94M
-4,233.33%-780K
-1,983.89%-3.11M
178.95%159K
-437.10%-209K
91.49%-48K
91.13%-18K
-Change in other current liabilities
-161.07%-389K
-0.81%-372K
-615.69%-263K
2.51%-621K
55.49%-154K
-167.73%-149K
-96.28%-369K
115.79%51K
-52.39%-637K
-179.03%-346K
-Change in other working capital
4.71%-627K
-3.41%-849K
-43.52%-996K
85.01%-2.51M
20.75%-340K
96.95%-658K
-112.97%-821K
36.74%-694K
-239.46%-16.77M
74.19%-429K
Cash from discontinued investing activities
Operating cash flow
22.89%-25.19M
14.02%-28.26M
1.28%-36.73M
-48.14%-138.2M
-65.91%-35.47M
-13.45%-32.66M
-116.44%-32.87M
-33.16%-37.2M
-2.56%-93.29M
14.63%-21.38M
Investing cash flow
Cash flow from continuing investing activities
-59.09%10.85M
13.38%24.04M
115.11%49.38M
227.02%86.61M
150.61%15.93M
138.73%26.52M
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
Net PPE purchase and sale
82.91%-115K
81.35%-418K
28.04%-1.04M
58.09%-4.87M
77.82%-505K
85.84%-673K
12.22%-2.24M
28.71%-1.45M
-79.93%-11.61M
-29.60%-2.28M
Net intangibles purchase and sale
--0
--0
--0
---1.63M
--0
--0
---125K
---1.5M
--0
----
Net investment purchase and sale
-59.67%10.97M
3.77%24.45M
94.65%50.42M
264.57%93.1M
156.29%16.44M
142.67%27.19M
73.06%23.57M
13.94%25.9M
34.37%-56.57M
-1,004.77%-29.2M
Cash from discontinued investing activities
Investing cash flow
-59.09%10.85M
13.38%24.04M
115.11%49.38M
227.02%86.61M
150.61%15.93M
138.73%26.52M
91.61%21.2M
10.88%22.96M
26.88%-68.18M
-2,790.09%-31.47M
Financing cash flow
Cash flow from continuing financing activities
13.52%277K
-95.45%6K
-96.25%468K
-89.16%16.72M
9,083.72%3.86M
-99.82%244K
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
Net common stock issuance
13.52%277K
-30.04%468K
--0
-90.05%15.19M
2,710.62%2.95M
-99.82%244K
-96.14%669K
908.82%11.33M
--152.72M
---113K
Proceeds from stock option exercised by employees
--0
13.97%-462K
-59.52%468K
-2.92%1.53M
1,204.29%913K
--0
-327.54%-537K
122.74%1.16M
-26.02%1.58M
-44.88%70K
Cash from discontinued financing activities
Financing cash flow
13.52%277K
-95.45%6K
-96.25%468K
-89.16%16.72M
9,083.72%3.86M
-99.82%244K
-99.25%132K
660.35%12.49M
7,133.85%154.3M
-133.86%-43K
Net cash flow
Beginning cash position
-33.41%25.25M
-40.41%29.46M
-68.09%16.34M
-12.29%51.21M
-69.25%32.02M
-42.77%37.91M
-6.33%49.45M
-12.29%51.21M
-75.72%58.38M
26.75%104.1M
Current changes in cash
-138.42%-14.06M
63.45%-4.22M
844.84%13.12M
-385.91%-34.87M
70.36%-15.68M
-115.57%-5.9M
-185.75%-11.53M
68.50%-1.76M
96.06%-7.18M
-122.75%-52.9M
End cash Position
-65.05%11.19M
-33.41%25.25M
-40.41%29.46M
-68.09%16.34M
-68.09%16.34M
-69.25%32.02M
-42.77%37.91M
-6.33%49.45M
-12.29%51.21M
-12.29%51.21M
Free cash flow
24.10%-25.3M
18.61%-28.68M
5.94%-37.77M
-37.94%-144.71M
-52.13%-35.99M
0.61%-33.33M
-98.62%-35.23M
-33.97%-40.15M
-7.02%-104.9M
12.71%-23.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.89%-25.19M14.02%-28.26M1.28%-36.73M-48.14%-138.2M-65.91%-35.47M-13.45%-32.66M-116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M
Net income from continuing operations 20.57%-27.55M-43.51%-54.1M3.01%-39.99M-46.08%-149.11M-2.85%-35.49M-246.77%-34.68M-27.70%-37.7M-47.03%-41.23M-2.66%-102.07M-27.85%-34.51M
Operating gains losses --0--------73.53%-9K---13K---------------34K--0
Depreciation and amortization -46.39%631K36.33%1.17M64.08%1.17M11.40%3.93M60.00%1.18M-25.46%1.18M38.74%856K20.54%710K117.32%3.53M46.25%740K
Other non cash items -43.30%457K100.54%15K-90.94%156K-99.69%10K-87.94%263K21.02%806K-1,744.97%-2.78M561.92%1.72M21,933.33%3.28M415.48%2.18M
Change In working capital 50.11%-1.41M-80.64%554K-76.21%-1.5M30.12%-5.11M-185.63%-4.3M87.20%-2.82M-76.33%2.86M64.06%-849K-74.07%-7.32M4,025.00%5.02M
-Change in receivables -158.89%-149K-105.74%-40K108.16%510K-24.47%608K-145.93%-587K118.15%253K-36.64%697K236.87%245K-76.73%805K284.94%1.28M
-Change in prepaid assets 273.31%461K-42.95%340K162.14%471K-124.52%-433K-100.55%-5K82.31%-266K9.36%596K-141.86%-758K281.13%1.77M43.26%914K
-Change in payables and accrued expense -149.95%-550K-97.77%58K-428.88%-1.7M-76.46%1.78M-167.20%-2.44M-52.67%1.1M-38.80%2.6M119.58%516K1,084.64%7.56M306.85%3.63M
-Change in other current assets 95.01%-155K791.19%1.42M329.19%479K-8,097.92%-3.94M-4,233.33%-780K-1,983.89%-3.11M178.95%159K-437.10%-209K91.49%-48K91.13%-18K
-Change in other current liabilities -161.07%-389K-0.81%-372K-615.69%-263K2.51%-621K55.49%-154K-167.73%-149K-96.28%-369K115.79%51K-52.39%-637K-179.03%-346K
-Change in other working capital 4.71%-627K-3.41%-849K-43.52%-996K85.01%-2.51M20.75%-340K96.95%-658K-112.97%-821K36.74%-694K-239.46%-16.77M74.19%-429K
Cash from discontinued investing activities
Operating cash flow 22.89%-25.19M14.02%-28.26M1.28%-36.73M-48.14%-138.2M-65.91%-35.47M-13.45%-32.66M-116.44%-32.87M-33.16%-37.2M-2.56%-93.29M14.63%-21.38M
Investing cash flow
Cash flow from continuing investing activities -59.09%10.85M13.38%24.04M115.11%49.38M227.02%86.61M150.61%15.93M138.73%26.52M91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M
Net PPE purchase and sale 82.91%-115K81.35%-418K28.04%-1.04M58.09%-4.87M77.82%-505K85.84%-673K12.22%-2.24M28.71%-1.45M-79.93%-11.61M-29.60%-2.28M
Net intangibles purchase and sale --0--0--0---1.63M--0--0---125K---1.5M--0----
Net investment purchase and sale -59.67%10.97M3.77%24.45M94.65%50.42M264.57%93.1M156.29%16.44M142.67%27.19M73.06%23.57M13.94%25.9M34.37%-56.57M-1,004.77%-29.2M
Cash from discontinued investing activities
Investing cash flow -59.09%10.85M13.38%24.04M115.11%49.38M227.02%86.61M150.61%15.93M138.73%26.52M91.61%21.2M10.88%22.96M26.88%-68.18M-2,790.09%-31.47M
Financing cash flow
Cash flow from continuing financing activities 13.52%277K-95.45%6K-96.25%468K-89.16%16.72M9,083.72%3.86M-99.82%244K-99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K
Net common stock issuance 13.52%277K-30.04%468K--0-90.05%15.19M2,710.62%2.95M-99.82%244K-96.14%669K908.82%11.33M--152.72M---113K
Proceeds from stock option exercised by employees --013.97%-462K-59.52%468K-2.92%1.53M1,204.29%913K--0-327.54%-537K122.74%1.16M-26.02%1.58M-44.88%70K
Cash from discontinued financing activities
Financing cash flow 13.52%277K-95.45%6K-96.25%468K-89.16%16.72M9,083.72%3.86M-99.82%244K-99.25%132K660.35%12.49M7,133.85%154.3M-133.86%-43K
Net cash flow
Beginning cash position -33.41%25.25M-40.41%29.46M-68.09%16.34M-12.29%51.21M-69.25%32.02M-42.77%37.91M-6.33%49.45M-12.29%51.21M-75.72%58.38M26.75%104.1M
Current changes in cash -138.42%-14.06M63.45%-4.22M844.84%13.12M-385.91%-34.87M70.36%-15.68M-115.57%-5.9M-185.75%-11.53M68.50%-1.76M96.06%-7.18M-122.75%-52.9M
End cash Position -65.05%11.19M-33.41%25.25M-40.41%29.46M-68.09%16.34M-68.09%16.34M-69.25%32.02M-42.77%37.91M-6.33%49.45M-12.29%51.21M-12.29%51.21M
Free cash flow 24.10%-25.3M18.61%-28.68M5.94%-37.77M-37.94%-144.71M-52.13%-35.99M0.61%-33.33M-98.62%-35.23M-33.97%-40.15M-7.02%-104.9M12.71%-23.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More